N‐3 Fatty Acids Abrogate Dyslipidemia‐Induced Changes in Bile Acid Uptake, Synthesis, and Transport in Young and Aged Dyslipidemic Rats. Issue 1 (10th February 2019)

• Record Type: Journal Article
• Authors: Acharya, Pooja; Talahalli, Ramaprasad R.
• Is Part Of: Lipids. Volume 54:Issue 1(2019)
• Page Start: 39
• Page End: 51
• Publication Date: 2019-02-10
• Subjects: α‐Linolenic acid -- Bile acid transporters -- Eicosapentaenoic acid -- Enterohepatic circulation -- Docosahexaenoic acid -- Dyslipidemia; Lipids -- Periodicals; Lipids -- Periodicals; Lipiden; Lipides -- Périodiques; 547.77
• DOI: 10.1002/lipd.12125
• Languages: English
• ISSNs: 0024-4201

Abstract

Abstract: In this study, the effect of n‐3 fatty acids (FA) [α‐linolenic acid (ALA) and eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)] on the intestinal bile acid (BA) uptake, hepatic BA synthesis, and enterohepatic bile acid transporters (BAT) was assessed in young and aged dyslipidemic rats. Dyslipidemia was induced in young and aged rats by feeding a high‐fat (HF) diet. Experimental groups received diets containing canola oil (HF + CNO) and fish oil (HF + FO) as a source of ALA and EPA + DHA, respectively. After 60 days of feeding, intestinal BA uptake and expression of apical sodium‐dependent bile acid transporter ( Asbt), organic solute transporter‐alpha/beta ( Osta/b) messenger RNA (mRNA), and hepatic expression of Na + taurocholate cotransporting polypeptide ( Ntcp), bile salt export pump ( Bsep), cholesterol 7‐α hydroxylase A1 ( Cyp7a1), Farnesoid X receptor ( Fxr), small heterodimer partner‐1 (Shp), liver receptor homolog‐1 ( Lrh‐1), and hepatic nuclear factor‐4 alpha ( Hnf4a) mRNA were measured. Hepatic 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A (HMG‐CoA) reductase activity and total BA in serum, liver, and feces were assessed. The dyslipidemic HF group had: (1) increased intestinal BA uptake and Asbt and Osta/b mRNA expression, (2) increased BA in serum, (3) decreased hepatic expression of Ntcp, Bsep, and Cyp7a1 mRNA, (4) increased activity of HMG‐CoA reductase, (5) increased hepatic expression of Fxr and Shp mRNA, (6) decreased hepatic expression of Lrh‐1 and Hnf4a mRNA, and (7) decreased BA in feces, when compared to control, HF + CNO, and HF + FO groups. Immunostaining revealed increased expression of intestinal Asbt and hepatic Ntcp protein in the HF group when compared to control, HF + CNO, and HF + FO groups. n‐3 FA abrogated dyslipidemia‐induced changes in the intestinal uptake, hepatic synthesis, and enterohepatic transporters of BA in both young and aged rats. EPA + DHA was more effective than ALA in modulating dyslipidemia‐induced changes.